Blog Band - Page 67 of 265 - PharmaShots

Skip to content Skip to footer

Login orRegister

Biocon Biologics & Civica

Biocon Biologics Partners with Civica to extend access of Insulin Aspart in the US

ByRidhi RastogiMarch 7, 20250Comments

Astrazeneca

AstraZeneca Reports P-III (MATTERHORN) Trial Data of Imfinzi as Perioperative Therapy for Stage II-IVA G/GEJ Cancers

ByRidhi RastogiMarch 7, 20250Comments

Neurotech Pharma

Neurotech Pharmaceuticals Reports the US FDA Approval for Encelto to treat Macular Telangiectasia Type 2

ByRidhi RastogiMarch 7, 20250Comments

Tris Pharma

Tris Pharma Reports P-III Clinical Data of Cebranopadol to Treat Moderate-to-Severe Acute Pain

ByRidhi RastogiMarch 7, 20250Comments

Hutchmed

HUTCHMED Reports Enrollment Completion in P-II Trial of Fanregratinib for Intrahepatic Cholangiocarcinoma in China

ByRidhi RastogiMarch 7, 20250Comments

Biocon Biologics

Biocon Biologics Report the P-III Study Positive Results of Yesintek (Biosimilar, Stelara)

ByDipanshu DixitMarch 7, 20250Comments

ITM

ITM Reports Topline Data from P-III (COMPETE) Trial of ITM-11 at the ENETS 2025 Conference

ByRidhi RastogiMarch 6, 20250Comments

Suvoda

Suvoda Launches AI assistant Sofia to Streamline Clinical Trial Management

ByRidhi RastogiMarch 6, 20250Comments

ARS Pharma

ARS Pharmaceuticals’ neffy 1mg Secures the US FDA’s Approval to Treat Type I Allergic Reactions in Children

ByRidhi RastogiMarch 6, 20250Comments

Log in to your account